S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold

Celcuity (CELC) News Today

$17.24
+0.85 (+5.19%)
(As of 04/19/2024 ET)
SourceHeadline
marketbeat.com logoShort Interest in Celcuity Inc. (NASDAQ:CELC) Drops By 7.5%
marketbeat.com - April 16 at 5:16 PM
MarketBeat logoCelcuity (NASDAQ:CELC) Stock Rating Reaffirmed by Needham & Company LLC
americanbankingnews.com - April 14 at 4:38 AM
marketbeat.com logoCelcuity (NASDAQ:CELC) Given Buy Rating at Needham & Company LLC
marketbeat.com - April 12 at 8:24 AM
marketbeat.com logoCelcuity (NASDAQ:CELC) Stock Price Down 3.6%
marketbeat.com - April 8 at 1:46 PM
marketbeat.com logoCelcuity (NASDAQ:CELC) Shares Up 4.5%
marketbeat.com - April 4 at 2:25 PM
globenewswire.com logoCelcuity To Present at Upcoming Needham and Stifel Investor Conferences
globenewswire.com - April 4 at 7:05 AM
msn.com logoCelcuity (NASDAQ:CELC): A Biotech with Blockbuster Potential
msn.com - April 3 at 8:22 AM
finance.yahoo.com logoCelcuity Gains 12%, Insider Trades Reap Benefit
finance.yahoo.com - April 3 at 8:22 AM
finance.yahoo.com logoCelcuity Inc. (NASDAQ:CELC) Q4 2023 Earnings Call Transcript
finance.yahoo.com - April 1 at 3:39 PM
msn.com logoI Gave Birth At A US Hospital In 2023 — Let's Break Down My $65,000 Bill
msn.com - March 30 at 3:29 PM
msn.com logoOne dead, another in ICU after drug overdose
msn.com - March 30 at 3:29 PM
markets.businessinsider.com logoGedatolisib’s Promising Clinical Trial Performance and Market Potential Justify Buy Rating
markets.businessinsider.com - March 29 at 4:25 PM
marketbeat.com logoCelcuity (NASDAQ:CELC) Price Target Raised to $25.00
marketbeat.com - March 28 at 2:35 PM
marketbeat.com logoCelcuity (NASDAQ:CELC) Reaches New 1-Year High After Analyst Upgrade
marketbeat.com - March 28 at 12:36 PM
markets.businessinsider.com logoAnalysts Are Bullish on These Healthcare Stocks: Celcuity (CELC), Cara Therapeutics (CARA)
markets.businessinsider.com - March 28 at 10:37 AM
finance.yahoo.com logoQ4 2023 Celcuity Inc Earnings Call
finance.yahoo.com - March 28 at 10:37 AM
marketbeat.com logoCelcuity's (CELC) "Buy" Rating Reiterated at HC Wainwright
marketbeat.com - March 28 at 8:28 AM
finance.yahoo.com logoCelcuity Inc (CELC) Reports Full Year 2023 Financial Results and Highlights Key Developments
finance.yahoo.com - March 27 at 10:51 PM
benzinga.com logoRecap: Celcuity Q4 Earnings
benzinga.com - March 27 at 5:51 PM
globenewswire.com logoCelcuity Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
globenewswire.com - March 27 at 4:01 PM
marketbeat.com logoCelcuity (CELC) Scheduled to Post Quarterly Earnings on Thursday
marketbeat.com - March 20 at 7:46 AM
globenewswire.com logoCelcuity Inc. Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Webcast/Conference Call
globenewswire.com - March 20 at 7:05 AM
marketbeat.com logoCelcuity Inc. (NASDAQ:CELC) Sees Significant Growth in Short Interest
marketbeat.com - March 16 at 5:15 PM
finance.yahoo.com logoCELC Apr 2024 20.000 call
finance.yahoo.com - March 15 at 2:49 AM
globenewswire.com logoCelcuity to Participate in Leerink Partners Global Biopharma Conference 2024
globenewswire.com - March 6 at 7:05 AM
finance.yahoo.com logoCelcuity to Participate in Cowen’s 44th Annual Health Care Conference
finance.yahoo.com - February 28 at 11:05 AM
globenewswire.com logoCelcuity to Participate in Cowen's 44th Annual Health Care Conference
globenewswire.com - February 28 at 7:05 AM
msn.com logoCelcuity (CELC) Price Target Increased by 12.99% to 27.95
msn.com - February 25 at 9:46 AM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Ligand Pharma (LGND) and Celcuity (CELC)
markets.businessinsider.com - February 23 at 5:59 PM
msn.com logoStifel Initiates Coverage of Celcuity (CELC) with Buy Recommendation
msn.com - February 23 at 2:57 AM
msn.com logoStifel starts Celcuity at buy, sees gedatolisib as potential blockbuster
msn.com - February 22 at 9:56 PM
finance.yahoo.com logoCelcuity Announces First Patient Dosed in Phase 1b/2 CELC-G-201 Clinical Trial of Gedatolisib for the Treatment of Metastatic Castration Resistant Prostate Cancer
finance.yahoo.com - February 22 at 9:56 PM
finanznachrichten.de logoCelcuity Inc.: Celcuity Appoints Eldon Mayer as Chief Commercial Officer
finanznachrichten.de - February 20 at 8:47 AM
finance.yahoo.com logoCelcuity Appoints Eldon Mayer as Chief Commercial Officer
finance.yahoo.com - February 20 at 8:47 AM
globenewswire.com logoCelcuity Appoints Eldon Mayer as Chief Commercial Officer
globenewswire.com - February 20 at 7:05 AM
marketbeat.com logoCelcuity Inc. (NASDAQ:CELC) Sees Large Increase in Short Interest
marketbeat.com - January 28 at 9:40 AM
finance.yahoo.com logoCelcuity Inc. (NASDAQ:CELC) has caught the attention of institutional investors who hold a sizeable 33% stake
finance.yahoo.com - January 22 at 10:13 AM
fool.com logoCelcuity (NASDAQ: CELC)
fool.com - January 11 at 7:56 AM
marketbeat.com logoCelcuity Inc. (NASDAQ:CELC) Short Interest Up 27.8% in December
marketbeat.com - December 31 at 3:09 PM
nasdaq.com logoHC Wainwright & Co. Initiates Coverage of Celcuity (CELC) with Buy Recommendation
nasdaq.com - December 9 at 12:09 AM
benzinga.com logoCelcuity Stock (NASDAQ:CELC), Analyst Ratings, Price Targets, Predictions
benzinga.com - December 8 at 7:09 PM
finance.yahoo.com logoCelcuity Presents Preclinical Data on Therapeutic Effects of Gedatolisib in Breast Cancer Models at the 2023 San Antonio Breast Cancer Symposium
finance.yahoo.com - December 6 at 8:45 AM
finance.yahoo.com logoCelcuity to Present Preclinical Data for Gedatolisib at the 2023 San Antonio Breast Cancer Symposium
finance.yahoo.com - December 1 at 3:23 PM
finance.yahoo.com logoCelcuity to Participate in the 6th Annual Evercore ISI HealthCONx Conference
finance.yahoo.com - November 22 at 8:45 AM
finance.yahoo.com logoCelcuity Inc. (NASDAQ:CELC) Q3 2023 Earnings Call Transcript
finance.yahoo.com - November 14 at 2:59 PM
finance.yahoo.com logoQ3 2023 Celcuity Inc Earnings Call
finance.yahoo.com - November 13 at 11:45 PM
finance.yahoo.com logoCelcuity Inc (CELC) Reports Q3 2023 Financial Results and Strategic Developments
finance.yahoo.com - November 13 at 1:44 PM
finance.yahoo.com logoCelcuity Inc. Reports Third Quarter 2023 Financial Results and Provides Corporate Updates
finance.yahoo.com - November 13 at 8:44 AM
bizjournals.com logoCancer research company Celcuity raises $50 million
bizjournals.com - November 7 at 9:48 PM
finance.yahoo.com logoCelcuity Inc. Schedules Release of Third Quarter 2023 Financial Results and Webcast/Conference Call
finance.yahoo.com - November 6 at 9:14 AM
Get Celcuity News Delivered to You Automatically

Sign up to receive the latest news and ratings for CELC and its competitors with MarketBeat's FREE daily newsletter.

Secret Bull Market Starts in This Unusual Sector (Ad)

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

Click for my No. 1 investment, all free of charge, click here. 

CELC Media Mentions By Week

CELC Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CELC
News Sentiment

0.61

0.52

Average
Medical
News Sentiment

CELC News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CELC Articles
This Week

2

1

CELC Articles
Average Week

Get Celcuity News Delivered to You Automatically

Sign up to receive the latest news and ratings for CELC and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:CELC) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners